These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


255 related items for PubMed ID: 22098285

  • 1. The EORTC QLQ-BN20 for assessment of quality of life in patients receiving treatment or prophylaxis for brain metastases: a literature review.
    Leung A, Lien K, Zeng L, Nguyen J, Caissie A, Culleton S, Holden L, Chow E.
    Expert Rev Pharmacoecon Outcomes Res; 2011 Dec; 11(6):693-700. PubMed ID: 22098285
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Quality of life in patients with primary and metastatic brain cancer as reported in the literature using the EORTC QLQ-BN20 and QLQ-C30.
    Chiu L, Chiu N, Zeng L, Zhang L, Popovic M, Chow R, Lam H, Poon M, Chow E.
    Expert Rev Pharmacoecon Outcomes Res; 2012 Dec; 12(6):831-7. PubMed ID: 23252363
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Symptoms and quality of life in chronic pancreatitis assessed by structured interview and the EORTC QLQ-C30 and QLQ-PAN26.
    Fitzsimmons D, Kahl S, Butturini G, van Wyk M, Bornman P, Bassi C, Malfertheiner P, George SL, Johnson CD.
    Am J Gastroenterol; 2005 Apr; 100(4):918-26. PubMed ID: 15784041
    [Abstract] [Full Text] [Related]

  • 8. Comparison of the EORTC QLQ-C15-PAL and the FACIT-Pal for assessment of quality of life in patients with advanced cancer.
    Lien K, Zeng L, Nguyen J, Cramarossa G, Culleton S, Caissie A, Lutz S, Chow E.
    Expert Rev Pharmacoecon Outcomes Res; 2011 Oct; 11(5):541-7. PubMed ID: 21958099
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Assessment of change of quality of life in terminally ill patients under cancer pain management using the EORTC Core Quality of Life Questionnaire (QLQ-C30) in a Korean sample.
    Park KU.
    Oncology; 2008 Oct; 74 Suppl 1():7-12. PubMed ID: 18758191
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Implementation of computer-based quality-of-life monitoring in brain tumor outpatients in routine clinical practice.
    Erharter A, Giesinger J, Kemmler G, Schauer-Maurer G, Stockhammer G, Muigg A, Hutterer M, Rumpold G, Sperner-Unterweger B, Holzner B.
    J Pain Symptom Manage; 2010 Feb; 39(2):219-29. PubMed ID: 20152586
    [Abstract] [Full Text] [Related]

  • 13. Translation and validation of the Urdu version of the European organization for research and treatment of cancer core quality of life questionnaire (EORTC QLQ-C30) and brain module (QLQ-BN20) in primary brain tumor patients.
    Zahid N, Martins RS, Zahid W, Khalid W, Azam I, Bhamani SS, Asad N, Ahmad K, Jabbar AA, Shamim MS, Khan RJ, Javed G, Bari E, Enam SA.
    J Patient Rep Outcomes; 2021 Sep 06; 5(1):79. PubMed ID: 34487251
    [Abstract] [Full Text] [Related]

  • 14. Minimal clinically important differences in the EORTC QLQ-BN20 in patients with brain metastases.
    Wong E, Zhang L, Kerba M, Arnalot PF, Danielson B, Tsao M, Bedard G, Thavarajah N, Cheon P, Danjoux C, Pulenzas N, Chow E.
    Support Care Cancer; 2015 Sep 06; 23(9):2731-7. PubMed ID: 25663577
    [Abstract] [Full Text] [Related]

  • 15. The European Organization for Research and Treatment of Cancer (EORTC) Quality-of-Life questionnaire cervical cancer module: EORTC QLQ-CX24.
    Greimel ER, Kuljanic Vlasic K, Waldenstrom AC, Duric VM, Jensen PT, Singer S, Chie W, Nordin A, Bjelic Radisic V, Wydra D, European Organization for Research and Treatment of Cancer Quality-of-Life Group.
    Cancer; 2006 Oct 15; 107(8):1812-22. PubMed ID: 16977652
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Translation and validation of the EORTC brain cancer module (EORTC QLQ-BN20) for use in Iran.
    Khoshnevisan A, Yekaninejad MS, Ardakani SK, Pakpour AH, Mardani A, Aaronson NK.
    Health Qual Life Outcomes; 2012 May 20; 10():54. PubMed ID: 22607028
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.